From: Adrenal insufficiency and the use of mineralocorticoid treatment in male patients with adrenoleukodystrophy; a retrospective analysis of an institutional database
Variable
All male ALD1 patients (N = 358)
Adrenal insufficiency, n (%)
213 (59.5%)
Fludrocortisone, n (%)
84 (23.5%)